AFECTACION HEPATICA EN LA ENFERMEDAD POR DEPOSITO DE ESTERES DE COLESTEROL
Atiénzar M, Hardisson D, Gutiérrez C*
BIBLIOGRAFÍA
Di Bisceglie AM; Ishak KG; Rabin L; Hoeg JM. Cholesteryl ester storage disease: hepatopathology and effects of therapy with lavastatin. Hepatology. 1990 May. 11(5). P 764-72.
Elleder M; Ledvinova J; Cieslar P; Kuhn R. Subclinical course of cholesterol ester storsge disease (CESD) diagnosed in adulthood. Report of two cases with remarks on the nature of the liver storage process. Virchows Arch A Pathol Anat Histopathol. 1990. 416(4). P 357-65.
Hautekeete ML; Degott C; Benhamou JP.Microvesicular steatosis of the liver. Acta Clin Belg. 1990. 45(5). P 311-26.
D´Agostino D; Bay L; Gallo G; Chamoles N. Cholesterol ester storage disease: clinical, biochemical and pathological studies of four new cases. Journal of Pediatric Gastroenterology and Nutrition. 7:446-450. 1988.
Aslanidis C; Ries S; Fehringer P; Buchler C; Klima H; Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 1996 Apr 1;33(1): 85-93.
Navarro C; Fernandez JM; Dominguez C; Ortega A; Sancho S; Garcia J. Muscle involvement in cholesterol ester storage disease. Neurology. 1992 May. 42(5). P 1120-1.
Perez Rodriguez-Cuesta, JM; Suarez Tomas JI; Suarez Menendez ME; Dominguez Gonzalez J. Enfermedad de depósito de ésteres de colesterol en dos hermanos. An Esp Pediatr. 32. 3(249-252). 1990.
Tarantino MD; McNamara DJ; Ganstrom P; Ellefson RD; Unger EC; Udall JN. Lovastatin therapy for cholesterol ester storage disease in two sisters. J Pediatr. 1991. Jan. 118(1). P 131-5.
|
|
Atiénzar M, Hardisson D, Gutiérrez C*
Copyright © 1998. Reservados todos los derechos.
